查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684489

全球眼保健產品市場：產業分析、規模、佔有率、成長、趨勢與預測（2025-2032 年）

Eye Health Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

重要考察

  • 眼部保健產品市場規模：30.194 億美元（2025 年）
  • 預計金額：50.93億美元（2032年）
  • 全球市場成長率：7.50%（2025年至2032年的複合年成長率）

眼保健產品市場 - 報告範圍

眼部保健產品市場包括營養補充品和旨在改善視力和預防眼部疾病的特殊配方。這些產品含有葉黃素、玉米黃質、 Omega-3脂肪酸、抗氧化劑和黃酮類化合物等必需營養素，可支持眼睛功能和整體健康。隨著人們對視力保健認知的不斷提高、眼科疾病率的上升以及消費者對預防性醫療保健解決方案的需求不斷增加，市場正在不斷擴大。

市場成長動力

老齡化黃斑部病變(AMD)、白內障和乾眼症盛行率上升等多種因素正在推動全球眼部保健產品市場的成長。由於使用數位設備而導致的螢幕時間增加，導致了視力相關問題的增加，從而推動了對眼部保健補充劑的需求。此外，持續的營養研究和老年人口的不斷成長進一步推動了市場的成長。用於眼部的綜合維他命混合物等創新配方的出現也推動了產品的採用。

市場限制

儘管具有巨大的成長潛力，但眼保健產品市場仍面臨產品成本高、開發中國家中市場認知度低等挑戰。此外，補充劑配方缺乏標準化以及與健康聲明相關的監管挑戰也可能阻礙市場擴張。此外，處方藥和手術干預等替代治療方法的存在可能會對眼部保健補充劑構成競爭挑戰。

市場機會

由於對天然和植物來源補充劑的需求不斷增加，眼部保健產品市場提供了巨大的成長機會。個人化營養和數位健康解決方案的整合有望提高產品功效和消費者參與度。此外，與醫療保健專業人士、眼科醫生和電子商務平台建立策略夥伴關係可能會推動市場滲透。分銷網路的擴張，特別是在新興經濟體的擴張，預計將進一步促進市場成長。

本報告研究了全球眼保健產品市場，並對市場動態進行了詳細分析，包括成長動力、趨勢、機會和挑戰。

目錄

第1章執行摘要

第2章 市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含和排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章 關鍵成功因素

  • 產品採用率 - 關鍵統計數據
  • 監管情景
  • 疾病流行病學
  • 產品獨特賣點分析
  • PESTEL 分析
  • 波特的分析

第5章 市場背景

  • 宏觀經濟因素
  • 預測因子－相關性和影響力
  • 市場動態

第6章 新冠疫情危機分析

  • COVID-19 及其影響分析
    • 按成分
    • 按適應症
    • 按形狀
    • 按地區
  • 市場狀況（2021年）

第7章 全球眼保健產品市場需求展望（2019-2032）

  • 市場金額表現分析（2019-2024）
  • 當前和未來市場金額分析與預測（2025-2032）
    • 與前一年同期比較趨勢分析
    • 絕對商機分析

第8章 全球眼保健產品市場展望（2019-2032）

  • 簡介/主要發現
  • 市場規模表現分析：依組件（2019-2024）
  • 目前及未來市場規模分析及預測（2025-2032 年）
    • 葉黃素、玉米黃質
    • 抗氧化劑
    • Omega-3脂肪酸
    • Coenzyme Q10
    • 黃酮類化合物
    • 蝦青素
    • 硫辛酸
    • 其他成分
  • 按原料進行市場吸引力分析

第9章 全球眼保健產品市場展望（2019-2032）

  • 簡介/主要發現
  • 市場規模表現分析：依適應症分類（2019-2024）
  • 當前及未來市場規模分析及預測（2025-2032）
    • 老齡化黃斑部病變(AMD)
    • 白內障
    • 乾眼症
    • 其他適應症
  • 按適應症進行市場吸引力分析

第 10 章全球眼保健產品市場展望（2019-2032 年）

  • 簡介/主要發現
  • 市場規模表現分析：依形狀（2019-2024）
  • 當前及未來市場規模分析及預測（按形狀）（2025-2032）
    • 錠劑
    • 膠囊
    • 其他
  • 按形狀分析市場吸引力

第 11 章 全球眼保健產品市場展望（2019-2032 年）

  • 介紹
  • 市場規模表現分析：按地區（2019-2024）
  • 當前和未來市場金額分析與預測（2025-2032）
    • 北美洲
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲
  • 按地區分析市場吸引力

第 12 章。北美眼保健產品市場展望（2019-2032 年）

第 13 章拉丁美洲眼保健產品市場展望（2019-2032 年）

第 14 章。歐洲眼保健產品市場展望（2019-2032 年）

第 15 章 東亞眼保健產品市場展望（2019-2032 年）

第 16 章 南亞眼保健產品市場展望（2019-2032 年）

第 17 章 大洋洲眼部保健產品市場展望（2019-2032 年）

第 18 章。中東和非洲眼保健產品市場展望（2019-2032 年）

第19章市場結構分析

  • 市場分析：依公司層級
  • 主要企業市場佔有率分析
  • 市場影響分析

第20章 競爭分析

  • 競爭儀錶板
  • 競爭基準
  • 衝突詳情
    • Pfizer Inc.
    • The Nature's Bounty Co.
    • Amway International
    • Bausch+Lomb
    • Nutrivein
    • ZeaVision LLC
    • Kemin Industries, Inc.
    • EyeScience
    • Nutrachamps
    • Bausch Health Companies Inc.
    • Vitabiotics Ltd.

第 21 章 使用的假設與縮寫

第 22 章調查方法

簡介目錄
Product Code: PMRREP5465

Persistence Market Research has recently released a comprehensive report on the global Eye Health Products Market, providing an in-depth analysis of key market dynamics, including growth drivers, emerging trends, opportunities, and challenges. This report offers valuable insights into the market structure, equipping stakeholders with the knowledge needed to make strategic decisions.

Key Insights:

  • Eye Health Products Market Size (2025E): USD 3,019.40 Mn
  • Projected Market Value (2032F): USD 5,009.30 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.50%

Eye Health Products Market - Report Scope:

The Eye Health Products Market includes dietary supplements and specialized formulations aimed at improving vision and preventing eye-related disorders. These products contain essential nutrients such as lutein, zeaxanthin, omega-3 fatty acids, antioxidants, and flavonoids, which support eye function and overall ocular health. The market is expanding due to increasing awareness about vision care, the rising prevalence of eye disorders, and growing consumer demand for preventive healthcare solutions.

Market Growth Drivers:

Several factors are fueling the growth of the global Eye Health Products Market, including the rising incidence of age-related macular degeneration (AMD), cataracts, and dry eye syndrome. Growing screen time due to digital device usage has led to an increase in vision-related issues, driving demand for eye health supplements. Additionally, advancements in nutritional research, coupled with the expanding geriatric population, are further propelling market growth. The availability of innovative formulations, such as multivitamin blends for eye health, is also enhancing product adoption.

Market Restraints:

Despite strong growth potential, the Eye Health Products Market faces challenges such as high product costs and limited awareness in developing regions. The lack of standardization in supplement formulations and regulatory challenges related to claims of health benefits may also hinder market expansion. Additionally, the presence of alternative treatment methods, such as prescription medications and surgical interventions, could pose a competitive challenge to eye health supplements.

Market Opportunities:

The Eye Health Products Market presents significant opportunities for growth due to increasing demand for natural and plant-based supplements. The integration of personalized nutrition and digital health solutions is expected to enhance product effectiveness and consumer engagement. Additionally, strategic partnerships with healthcare professionals, ophthalmologists, and e-commerce platforms can drive market penetration. Expanding distribution networks, particularly in emerging economies, will further contribute to market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the Eye Health Products Market?
  • Which ingredients and formulations are gaining the most traction in the eye health industry?
  • How is digitalization and increased screen exposure impacting market trends?
  • Who are the major players in the Eye Health Products Market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future outlooks for the global Eye Health Products Market?

Competitive Intelligence and Business Strategy:

Leading companies in the Eye Health Products Market, including The Nature's Bounty Co., Pfizer Inc., Amway International, and Bausch + Lomb, are focusing on product innovation, clinical research, and strategic collaborations to strengthen their market position. Companies are investing in scientific advancements to develop high-potency supplements with enhanced bioavailability. E-commerce expansion, digital marketing strategies, and retail partnerships are also being leveraged to improve consumer outreach. The focus on sustainability and clean-label products is becoming a key differentiator in the competitive landscape.

Key Companies Profiled:

  • The Nature's Bounty Co.
  • Pfizer Inc.
  • Amway International
  • Bausch + Lomb
  • Nutrivein
  • ZeaVision LLC
  • Kemin Industries, Inc.
  • EyeScience
  • Nutrachamps
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.

Eye Health Products Industry Research by Category:

By Ingredient:

  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 Fatty Acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic Acid
  • Other Ingredients

By Indication:

  • Age-related Macular Degeneration (AMD)
  • Cataract
  • Dry Eye Syndrome
  • Other Indications

By Form:

  • Tablet
  • Capsule
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmaps
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Rate - Key Statistics
  • 4.2. Regulatory Scenario
  • 4.3. Disease Epidemiology
  • 4.4. Product USP Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Eye Care Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Eye Disorders
    • 5.2.2. Growing Awareness of Eye Diseases
    • 5.2.3. Rising Demand of Eye Health Products Amongst Millennials
    • 5.2.4. Advertisement from Manufacturers
    • 5.2.5. Mergers and Acquisitions
    • 5.2.6. Prevalence of AMD in Elderly Population
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Ingredient
    • 6.1.2. By Indication
    • 6.1.3. By Form
    • 6.1.4. By Region
  • 6.2. 2021 Market Scenario

7. Global Eye Health Products Market Demand Outlook, 2019 - 2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
  • 7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Eye Health Products Market Outlook, 2019 - 2032

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis, by Ingredient, 2019-2024
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Ingredient, 2025-2032
    • 8.3.1. Lutein and Zeaxanthin
    • 8.3.2. Antioxidants
    • 8.3.3. Omega-3 Fatty Acids
    • 8.3.4. Coenzyme Q10
    • 8.3.5. Flavonoids
    • 8.3.6. Astaxanthin
    • 8.3.7. Alpha-Lipoic Acid
    • 8.3.8. Other Ingredients
  • 8.4. Market Attractiveness Analysis, by Ingredient

9. Global Eye Health Products Market Outlook, 2019 - 2032

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2024
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Indication, 2025-2032
    • 9.3.1. Age-related Macular Degeneration (AMD)
    • 9.3.2. Cataract
    • 9.3.3. Dry Eye Syndrome
    • 9.3.4. Other Indications
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Eye Health Products Market Outlook, 2019 - 2032

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Form, 2019-2024
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Form, 2025-2032
    • 10.3.1. Tablet
    • 10.3.2. Capsule
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis, by Form

11. Global Eye Health Products Market Outlook, 2019 - 2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2024
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Eye Health Products Market Outlook, 2019 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Ingredient
    • 12.3.3. By Indication
    • 12.3.4. By Form
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Ingredient
    • 12.4.3. By Indication
    • 12.4.4. By Form
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Eye Health Products Market Analysis
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.1.2.1. By Ingredient
        • 12.7.1.2.2. By Indication
        • 12.7.1.2.3. By Form
    • 12.7.2. Canada Eye Health Products Market Analysis
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.2.2.1. By Ingredient
        • 12.7.2.2.2. By Indication
        • 12.7.2.2.3. By Form

13. Latin America Eye Health Products Market Outlook, 2019 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Ingredient
    • 13.3.3. By Indication
    • 13.3.4. By Form
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Ingredient
    • 13.4.3. By Indication
    • 13.4.4. By Form
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Mexico Eye Health Products Market Analysis
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.1.2.1. By Ingredient
        • 13.7.1.2.2. By Indication
        • 13.7.1.2.3. By Form
    • 13.7.2. Brazil Eye Health Products Market Analysis
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.2.2.1. By Ingredient
        • 13.7.2.2.2. By Indication
        • 13.7.2.2.3. By Form
    • 13.7.3. Argentina Eye Health Products Market Analysis
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.3.2.1. By Ingredient
        • 13.7.3.2.2. By Indication
        • 13.7.3.2.3. By Form

14. Europe Eye Health Products Market Outlook, 2019-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Ingredient
    • 14.3.3. By Indication
    • 14.3.4. By Form
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Ingredient
    • 14.4.3. By Indication
    • 14.4.4. By Form
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Eye Health Products Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Ingredient
        • 14.7.1.2.2. By Indication
        • 14.7.1.2.3. By Form
    • 14.7.2. Italy Eye Health Products Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Ingredient
        • 14.7.2.2.2. By Indication
        • 14.7.2.2.3. By Form
    • 14.7.3. France Eye Health Products Market Analysis
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.3.2.1. By Ingredient
        • 14.7.3.2.2. By Indication
        • 14.7.3.2.3. By Form
    • 14.7.4. U.K. Eye Health Products Market Analysis
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.4.2.1. By Ingredient
        • 14.7.4.2.2. By Indication
        • 14.7.4.2.3. By Form
    • 14.7.5. Spain Eye Health Products Market Analysis
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.5.2.1. By Ingredient
        • 14.7.5.2.2. By Indication
        • 14.7.5.2.3. By Form
    • 14.7.6. BENELUX Eye Health Products Market Analysis
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.6.2.1. By Ingredient
        • 14.7.6.2.2. By Indication
        • 14.7.6.2.3. By Form
    • 14.7.7. Russia Eye Health Products Market Analysis
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.7.2.1. By Ingredient
        • 14.7.7.2.2. By Indication
        • 14.7.7.2.3. By Form

15. East Asia Eye Health Products Market Outlook, 2019 - 2032

  • 15.1. Introduction
  • 15.2. Historical Market Form (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Ingredient
    • 15.3.3. By Indication
    • 15.3.4. By Form
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Ingredient
    • 15.4.2. By Indication
    • 15.4.3. By Form
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. China Eye Health Products Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Ingredient
        • 15.7.1.2.2. By Indication
        • 15.7.1.2.3. By Form
    • 15.7.2. Japan Eye Health Products Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Ingredient
        • 15.7.2.2.2. By Indication
        • 15.7.2.2.3. By Form
    • 15.7.3. South Korea Eye Health Products Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Ingredient
        • 15.7.3.2.2. By Indication
        • 15.7.3.2.3. By Form

16. South Asia Eye Health Products Market Outlook, 2019-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Ingredient
    • 16.3.3. By Indication
    • 16.3.4. By Form
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Ingredient
    • 16.4.3. By Indication
    • 16.4.4. By Form
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. India Eye Health Products Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Ingredient
        • 16.7.1.2.2. By Indication
        • 16.7.1.2.3. By Form
    • 16.7.2. Indonesia Eye Health Products Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Ingredient
        • 16.7.2.2.2. By Indication
        • 16.7.2.2.3. By Form
    • 16.7.3. Malaysia Eye Health Products Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Ingredient
        • 16.7.3.2.2. By Indication
        • 16.7.3.2.3. By Form
    • 16.7.4. Thailand Eye Health Products Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Ingredient
        • 16.7.4.2.2. By Indication
        • 16.7.4.2.3. By Form

17. Oceania Eye Health Products Market Outlook, 2019 - 2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Ingredient
    • 17.3.3. By Indication
    • 17.3.4. By Form
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Ingredient
    • 17.4.3. By Indication
    • 17.4.4. By Form
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Eye Health Products Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Ingredient
        • 17.7.1.2.2. By Indication
        • 17.7.1.2.3. By Form
    • 17.7.2. New Zealand Eye Health Products Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Ingredient
        • 17.7.2.2.2. By Indication
        • 17.7.2.2.3. By Form

18. Middle East and Africa (MEA) Eye Health Products Market Outlook, 2019 - 2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Ingredient
    • 18.3.3. By Indication
    • 18.3.4. By Form
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Ingredient
    • 18.4.2. By Indication
    • 18.4.3. By Form
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Eye Health Products Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Ingredient
        • 18.7.1.2.2. By Indication
        • 18.7.1.2.3. By Form
    • 18.7.2. Turkey Eye Health Products Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Ingredient
        • 18.7.2.2.2. By Indication
        • 18.7.2.2.3. By Form
    • 18.7.3. South Africa Eye Health Products Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Ingredient
        • 18.7.3.2.2. By Indication
        • 18.7.3.2.3. By Form
    • 18.7.4. North Africa Eye Health Products Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Ingredient
        • 18.7.4.2.2. By Indication
        • 18.7.4.2.3. By Form

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Pfizer Inc.
      • 20.3.1.1. Overview
      • 20.3.1.2. Ingredient Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Ingredient Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. The Nature's Bounty Co.
      • 20.3.2.1. Overview
      • 20.3.2.2. Ingredient Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Ingredient Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Amway International
      • 20.3.3.1. Overview
      • 20.3.3.2. Ingredient Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Ingredient Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Bausch + Lomb
      • 20.3.4.1. Overview
      • 20.3.4.2. Ingredient Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Ingredient Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. Nutrivein
      • 20.3.5.1. Overview
      • 20.3.5.2. Ingredient Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Ingredient Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. ZeaVision LLC
      • 20.3.6.1. Overview
      • 20.3.6.2. Ingredient Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Ingredient Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Kemin Industries, Inc.
      • 20.3.7.1. Overview
      • 20.3.7.2. Ingredient Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Ingredient Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. EyeScience
      • 20.3.8.1. Overview
      • 20.3.8.2. Ingredient Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Ingredient Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Nutrachamps
      • 20.3.9.1. Overview
      • 20.3.9.2. Ingredient Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Ingredient Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. Bausch Health Companies Inc.
      • 20.3.10.1. Overview
      • 20.3.10.2. Ingredient Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Ingredient Strategy
        • 20.3.10.6.3. Channel Strategy
    • 20.3.11. Vitabiotics Ltd.
      • 20.3.11.1. Overview
      • 20.3.11.2. Ingredient Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Marketing Strategy
        • 20.3.11.6.2. Ingredient Strategy
        • 20.3.11.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology